Publication

Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics

Downloadable Content

Persistent URL
Last modified
  • 05/20/2025
Type of Material
Authors
    Simon Melov, Buck Institute for Age Research, NovatoSusan R. Doctrow, Eukarion Inc., BedfordJulie A. Schneider, Rush-Presbyterian St. Luke's HospitalJoanna Haberson, Buck Institute for Age Research, NovatoManisha Patel, Emory UniversityPinar E. Coskun, Emory UniversityKarl Huffman, Eukarion Inc., BedfordDouglas C. Wallace, Emory UniversityBernard Malfroy, Eukarion Inc., Bedford
Language
  • English
Date
  • 2001-11-01
Publisher
  • Lippincott, Williams & Wilkins
Publication Version
Copyright Statement
  • © 2001 Society for Neuroscience
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0888-0395
Volume
  • 21
Issue
  • 21
Start Page
  • 8348
End Page
  • 8353
Grant/Funding Information
  • This work was supported by National Institutes of Health Grants DCW-AG13154, HL45572, NS21328, and AG18679 (S.M.).
Abstract
  • Superoxide is produced as a result of normal energy metabolism within the mitochondria and is scavenged by the mitochondrial form of superoxide dismutase (sod2). Mice with inactivated SOD2 (sod2 nullizygous mice) die prematurely, exhibiting several metabolic and mitochondrial defects and severe tissue pathologies, including a lethal spongiform neurodegenerative disorder (Li et al., 1995; Melov et al., 1998, 1999). We show that treatment of sod2 nullizygous mice with synthetic superoxide dismutase (SOD)-catalase mimetics extends their lifespan by threefold, rescues the spongiform encephalopathy, and attenuates mitochondrial defects. This class of antioxidant compounds has been shown previously to extend lifespan in the nematode Caenorhabditis elegans (Melov et al., 2000). These new findings in mice suggest novel therapeutic approaches to neurodegenerative diseases associated with oxidative stress such as Friedreich ataxia, spongiform encephalopathies, and Alzheimer's and Parkinson's diseases, in which chronic oxidative damage to the brain has been implicated.
Author Notes
  • E-mail Address: smelov@ buckinstitute.org.
Keywords
Research Categories
  • Biology, Neuroscience
  • Biology, Animal Physiology
  • Chemistry, Biochemistry

Tools

Relations

In Collection:

Items